Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 426,311 |
|
|||||
| News | (1) | ||||||
| Day High | 0.7883 | Low High |
|||||
| Day Low | 0.7444 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AlloVir Inc | ALVR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0322 | -4.14% | 0.7465 | 18:00:03 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.7515 | 0.7444 | 0.7883 | 0.7465 | 0.7787 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,145 | 426,311 | $ 0.7508721 | $ 320,105 | - | 0.58 - 6.12 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:11:05 | 50 | $ 0.746 | USD |
AlloVir Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 86.69M | 114.06M | - | 0 | -190.42M | -1.67 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
AlloVir News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALVR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.7557 | 0.7994 | 0.74 | 0.774107 | 165,456 | -0.0092 | -1.22% |
| 1 Month | 0.765 | 0.82 | 0.58 | 0.7751784 | 309,685 | -0.0185 | -2.42% |
| 3 Months | 0.72 | 0.85 | 0.58 | 0.7635577 | 444,405 | 0.0265 | 3.68% |
| 6 Months | 1.55 | 2.485 | 0.58 | 0.8786819 | 1,330,991 | -0.8035 | -51.84% |
| 1 Year | 4.29 | 6.12 | 0.58 | 1.60 | 1,068,829 | -3.54 | -82.60% |
| 3 Years | 21.79 | 26.41 | 0.58 | 4.73 | 677,314 | -21.04 | -96.57% |
| 5 Years | 22.82 | 48.96 | 0.58 | 7.84 | 601,297 | -22.07 | -96.73% |
AlloVir Description
| AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. |
